NewAmsterdam Pharma
NAMSNasdaq NetherlandsHealth CareBiotechnology: Pharmaceutical Preparations
Market cap
$2.266 B
$18.90 -9.72%
Close of 6 Nov 2026
As of 6 Nov 2026, NewAmsterdam Pharma (NAMS) has a market capitalization of $2.27B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.
Revenue
$22.5M
#2937 by revenue
Earnings
-$203.0M
Loss-making
Shares outstanding
119,929,998
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Other share classes
NewAmsterdam Pharma lists more than one class of stock. Company figures above cover all classes combined.
Biotechnology: Pharmaceutical Preparations, ranked by market cap
All 498 →- #84MBX BiosciencesMBX$2.34B
- #85PharvarisPHVS$2.28B
- #86NewAmsterdam PharmaNAMS$2.27B
- #87SepternaSEPN$2.22B
- #88Lakefront BiotherapeuticsLKFT$2.22B
What if NewAmsterdam Pharma were worth as much as…
Open the what-if tool →Where these numbers come from
Share counts and financials for NewAmsterdam Pharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.